Self-Condensation Culture Enables Vascularization of Tissue Fragments for Efficient Therapeutic Transplantation.

Clinical transplantation of tissue fragments, including islets, faces a critical challenge because of a lack of effective strategies that ensure efficient engraftment through the timely integration of vascular networks. We recently developed a complex organoid engineering method by "self-condensation" culture based on mesenchymal cell-dependent contraction, thereby enabling dissociated heterotypic lineages including endothelial cells to self-organize in a spatiotemporal manner. Here, we report the successful adaptation of this method for generating complex tissues from diverse tissue fragments derived from various organs, including pancreatic islets. The self-condensation of human and mouse islets with endothelial cells not only promoted functionalization in culture but also massively improved post-transplant engraftment. Therapeutically, fulminant diabetic mice were more efficiently treated by a vascularized islet transplant compared with the conventional approach. Given the general limitations of post-transplant vascularization associated with 3D tissue-based therapy, our approach offers a promising means of enhancing efficacy in the context of therapeutic tissue transplantation.

[1]  B. Oh,et al.  Co‐Transplantation of Bone Marrow‐Derived Endothelial Progenitor Cells Improves Revascularization and Organization in Islet Grafts , 2013, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[2]  Takanori Takebe,et al.  Vascularized and functional human liver from an iPSC-derived organ bud transplant , 2013, Nature.

[3]  A. M. Shapiro,et al.  Human islet distribution program for basic research at a single center. , 2011, Transplantation proceedings.

[4]  K. Sekine,et al.  High-resolution intravital imaging for monitoring the transplanted islets in mice. , 2014, Transplantation proceedings.

[5]  E. Stanley,et al.  The functional and molecular characterisation of human embryonic stem cell-derived insulin-positive cells compared with adult pancreatic beta cells , 2012, Diabetologia.

[6]  K. Sekine,et al.  Generation of functional human vascular network. , 2012, Transplantation proceedings.

[7]  Daniel Eberhard,et al.  ‘Giving and taking’: endothelial and β-cells in the islets of Langerhans , 2010, Trends in Endocrinology & Metabolism.

[8]  P. Herrera,et al.  Genes controlling pancreas ontogeny. , 2008, The International journal of developmental biology.

[9]  Tatsuya Kin,et al.  A prevascularized subcutaneous device-less site for islet and cellular transplantation , 2015, Nature Biotechnology.

[10]  E. Hao,et al.  Human embryonic stem cell derived islet progenitors mature inside an encapsulation device without evidence of increased biomass or cell escape. , 2014, Stem cell research.

[11]  M. Yamada,et al.  Feasibility of ex vivo gene therapy for neurological disorders using the new retroviral vector GCDNsap packaged in the vesicular stomatitis virus G protein , 2002, Journal of neurochemistry.

[12]  K. Park,et al.  Endothelial Progenitor Cell Cotransplantation Enhances Islet Engraftment by Rapid Revascularization , 2012, Diabetes.

[13]  Taihei Ito,et al.  Mesenchymal Stem Cell and Islet Co-Transplantation Promotes Graft Revascularization and Function , 2010, Transplantation.

[14]  Qingzhong Xiao,et al.  Pluripotent stem cell differentiation into vascular cells: a novel technology with promises for vascular re(generation). , 2011, Pharmacology & therapeutics.

[15]  H. Yonekawa,et al.  Diphtheria toxin receptor–mediated conditional and targeted cell ablation in transgenic mice , 2001, Nature Biotechnology.

[16]  L. Dai,et al.  A protocol for islet isolation from mouse pancreas , 2009, Nature Protocols.

[17]  Y. Kikkawa,et al.  Generation of mouse models for type 1 diabetes by selective depletion of pancreatic beta cells using toxin receptor-mediated cell knockout. , 2013, Biochemical and biophysical research communications.

[18]  S. Chouaib,et al.  Human mesenchymal stem cells derived from induced pluripotent stem cells down-regulate NK-cell cytolytic machinery. , 2011, Blood.

[19]  E. Kroon,et al.  Production of pancreatic hormone–expressing endocrine cells from human embryonic stem cells , 2006, Nature Biotechnology.

[20]  Takanori Takebe,et al.  Generation of a vascularized and functional human liver from an iPSC-derived organ bud transplant , 2014, Nature Protocols.

[21]  Á. Meana,et al.  Cooperation by Fibroblasts and Bone Marrow-Mesenchymal Stem Cells to Improve Pancreatic Rat-to-Mouse Islet Xenotransplantation , 2013, PloS one.

[22]  E. Ryan,et al.  Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. , 2000, The New England journal of medicine.

[23]  Takanori Takebe,et al.  Vascularized and Complex Organ Buds from Diverse Tissues via Mesenchymal Cell-Driven Condensation. , 2015, Cell stem cell.

[24]  K. Sekine,et al.  Massive and Reproducible Production of Liver Buds Entirely from Human Pluripotent Stem Cells. , 2017, Cell reports.

[25]  A. Luttun,et al.  Human blood outgrowth endothelial cells improve islet survival and function when co-transplanted in a mouse model of diabetes , 2013, Diabetologia.

[26]  A. Shapiro,et al.  Bioengineered stem cells as an alternative for islet cell transplantation. , 2015, World journal of transplantation.

[27]  Tomoko Nakanishi,et al.  ‘Green mice’ as a source of ubiquitous green cells , 1997, FEBS letters.